Decision to not make a drug for childhood cancer on the NHS is 'devastating', say charities
Health watchdog Nice, which advises NHS England, stressed it would like to recommend dinutuximab beta for patients with neuroblastoma – but argued it is too expensive.
Source: the Mail online | Health - Category: Consumer Health News Source Type: news
More News: Brain | Cancer | Cancer & Oncology | Childhood Cancer | Health | National Institute for Health and Clinical Excelle | Neuroblastoma | Neurology